Expression of co-stimulatory molecules on langerhans cells in lesional epidermis of human atopic dermatitis

Immunopharmacology and Immunotoxicology

Volumn 29, Issue 3-4, 2007, Pages 487-498

  Fesenkova, Valentyna I ^a   Kurchenko, Anita I ^a   Castellani, Maria Luisa ^b   Conti, Pio ^b   Anogeianaki, Antonia ^c   Caraffa, Auro ^d   Kalogeromitros, Dimitris ^e  

^a BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^b UNIVERSITY OF CHIETI   (Italy)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d UNIVERSITY OF PERUGIA   (Italy)

^e Attikin University   (Greece)

Author keywords

Atopic Dermatitis; CD1a; CD80; CD86; Dendritic cell

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; T6 ANTIGEN; UPSTREAM STIMULATORY FACTOR;

ARTICLE; ATOPIC DERMATITIS; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; EPIDERMIS; GENE LOCUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LANGERHANS CELL; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ANIMALS; ANTIGENS, CD1; ANTIGENS, CD80; ANTIGENS, CD86; CHRONIC DISEASE; DERMATITIS, ATOPIC; ECZEMA; EPIDERMIS; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; MICE;

EID: 37149003666     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970701675101     Document Type: Article

References (51)

1. Schultz Larsen, F.; Diepgen, T.; Svensson, A. The occurrence of atopic dermatitis in north Europe: an international questional study. J. Am. Acad. Dermatol. 1996, 34, 760-764.
2. Novak, N.; Bieber, T.; Leung, D.Y.M. Immune mechanisms leading to atopic dermatitis. J. Allergy Clin. Immunol. 2003, 113, 651-657.
3. Marcucci, F.; Sensi, L.; Di Cara, G.; Gidaro, G.; Incorvaia, C.; Frati, F. Sublingual reactivity to rBET V1 and rPHL P1 in patients with oral allergy syndrome. Int. J. Immunopathol. Pharmacol. 2006, 19, 141-148.
4. Alexandrakis, M.G.; Passam, F.H.; Pappa, C.A.; Damilakis, G.; Kandidaki, E.; Passam, A.M.; Stathopoulos, E.N.; Kyriakou, D.S. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density. Int. J. Immunopathol. Pharmacol. 2005, 18, 287-295.
5. Charbonnier, A.S.; Kohrgruber, N., Kriehuber, E.; Stingl, G.; Rot, A.; Maurer, D. Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J. Exp. Med. 1999, 190, 1755-1768.
6. Komine, M.; Karakawa, M.; Takekoshi, T.; Sakurai, N.; Minatani, Y.; Mitsui, H.; Tada, Y.; Saeki, H.; Asahina, A.; Tamaki, K. Early inflammatory changes in the "perilesional skin" of psoriatic plaques: is there interaction between dendritic cells and keratinocytes? J. Invest. Dermatol. 2007, 127 (8), 1915-1922.
7. Rust, R.; Kluiver, J.; Visser, L.; Harms G.; Blokzijl, T.; Kamps, W.; Poppema, S.; van den Berg, A. Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis. J. Pathol. 2006, 209 (4), 474-483.
8. Marinova, S.; Nenkov, P.; Markova, R.; Nikolaeva, S.; Kostadinova, R.; Mitov, I.; Vretenarska, M. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections. Int. J. Immunopathol. Pharmacol. 2005, 18, 457-473.
9. Staibano, S.; Mascolo, M.; Tranfa, F.; Salvatore, G.; Mignogna, C.; Bufo, P.; Nugnes, L.; Bonavolontà, G.; De Rosa, G. Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behaviour? Int. J. Immunopathol. Pharmacol. 2006, 19, 171-180.
10. Yoo, J.; Omory, M.; Gyarmati, D.; Zhou, B.; et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J. Exp. Med. 2005, 202, 541-549.
11. Castellani, M.L.; Salini, V.; Frydas, S.; Donelan, J.; Tagen, M.; Madhappan, B.; Petrarca, C.; Falasca, K.; Neri, G.; Tete', S.; Vecchiet, J. The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity. Int. J. Immunopathol. Pharmacol. 2006, 19 (2), 247-252.
12. Martini, F.; Agrati, C.; D'Offizi, G.; Poccia, F. HLA-E UP-regulation induced by HIV infection may directly contribute to CD94-mediated impairment of NK cells. Int. J. Immunopathol. Pharmacol. 2005, 18, 269-276.
13. Carmignani, M.; Zucchetti, F.; Sacco, R.; Bolognini, S.; Volpe, A.R. Shock induction by arterial hypoperfusion of the gut involves synergistic interactions between the peripheral enkephalin and nitric oxide systems. Int. J. Immunopathol. Pharmacol. 2005, 18, 33-48.
14. Soumelis, V.; Reche, P.A.; Kanzler, H.; et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunol. 2002, 3, 673-680.
15. Ciprandi, G.; Cirillo, I.; Troisi, R.M.; Marseglia, G.L. Allergic subjects have more numerous respiratory infections and severe gastrointestinal infections than nonallergic subjects: preliminary results. Eur. J. Inflamm. 2007, 5, 27-30.
16. Bonsi, L.; Pierdomenico, L.; Biscardi, M.; Marchionni, C.; Gavazzi, S.; Fossati, V.; Ghinassi, B.; Alviano, F.; Rondelli, D.; Franchina, M.; Bagnara, G.P.; Grossi, A. Constitutive and stimulated production of VEGF by human megakaryoblastic cell lines: effect on proliferation and signaling pathway Int. J. Immunopathol. Pharmacol. 2005, 18, 445-455.
17. Lazarova, P.; Wu, Q.; Kvalheim, G.; Suo, Z.; Haakenstad, K.W.; Metodiev, K.; Nesland, J.M. Growth factor receptors in hematopoietic stem cells: Eph family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood. Int. J. Immunopathol. Pharmacol. 2006, 19, 49-56.
18. Ito, T.; Wang, Y.H.; Duramad, O.; Hori, T.; Delespesse, G.J.; Watanabe, N.; Qin, F.X.; Yao, Z.; Cao, W.; Liu, Y.J. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 2005, 202, 1213-1223.
19. Lesma, E.; Riva, E.; Giovannini, M.; Di Giulio, A.M.; Gorio, A. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b. Int. J. Immunopathol. Pharmacol. 2005, 18, 297-308.
20. Trubiani, O.; Di Primio, R.; Traini, T.; Pizzicannella, J.; Scarano, A.; Piattelli, A.; Caputi, S. Morphological and cytofluorimetric analysis of adult mesenchymal stem cells expanded ex vivo from periodontal ligament. Int. J. Immunopathol. Pharmacol. 2005, 18, 213-222.
21. Liu, Y.-J. Thymic stromal lymphopoietin: master switch for allergic inflammation. J. Exp. Med. 2006, 203, 269-273.
22. Inaba, K.; Witmer-Pack, M.; Inaba, M.; Hathcock, K.; et al. The tissue distribution of B7 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 1994, 180, 1849-1860.
23. Sansom, D.M.; Manzotty, C.N.; Zheng, Y. What's the difference between CD80 and CD86? Trends Immunol. 2003, 24, 313-318.
24. Feili-Hariri, M.; Falkner, D.H.; Morel, P.A. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. J. Leukoc. Biol. 2005, 78(3), 656-664.
25. Yamaki, K.; Uchida, H.; Li, X.; Yanagisawa, R.; Takano, H.; Hayashi, H.; Mori, Y.; Yoshino, S. Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol. 2005, 18, 133-144.
26. Esposito, I.; Perna, F.; Ponticiello, A.; Perrella, M.; Gilli, M.; Sanduzzi, A. Natural killer cells in baland peripheral blood of patients with idiopathic pulmonary fibrosis (IPF) Int. J. Immunopathol. Pharmacol. 2005, 18, 541-545.
27. D'Haene, N.; Maris, C.; Sandras, F.; Dehou, M.-F.; Remmelink, M.; Decaestecker, C.; Salmon, I. The differential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas Int. J. Immunopathol. Pharmacol. 2005, 18, 431-443.
28. Cavalieri, S.; Rotoli, M., Feliciani, C.; Amerio, P. Expression of the high-affinity laminin receptor (67 kDa) in normal human skin and appendages. Int. J. Immunopathol. Pharmacol. 2005, 18, 223-232.
29. Hanifin, J.M.; Rajka, G. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. Suppl. (Stockh) 1980, 92, 44-47.
30. Lee, Y.A.; Wahn, U.; Kehrt, R.; Tarani, L.; Businco, L.; Gustafsson, D.; Andersson, F.; Oranje, A.P., Wolkertstorfer, A.; van Berg, A.; Hoffmann, U.; Kuster, W.; Wienker, T.; Ruschendorf, F.; Reis, A. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat. Genet. 2000, 26, 470-473.
31. Appert-Collin, A.; Duong, F.H.T.; Passilly DeGrace, P.; Bennasroune, A.; Poindron, P.; Warter, J.-M.; Gies, J.P. Xaliproden (SR57746A) induces 5-HT1A receptors-mediated map kinase activation in PC12 cells. Int. J. Immunopathol. Pharmacol. 2005, 18, 233-244.
32. Liu, Q.; Hamblin, M.R. Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation state Int. J. Immunopathol. Pharmacol. 2005, 18, 391-402.
33. Avgerinos, D.V.; Theoharides, T.C. Mesenteric traction syndrome or gut in distress. Int. J. Immunopathol. Pharmacol. 2005, 18, 195-200.
34. Bieber, T.; de la Salle, H.; Wollenberg, A.; Hakimi, J.; Chizzonite, R.; Ring, J.; et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J. Exp. Med. 1992, 175, 1285-1290.
35. van der Heijden, F.L.; Joost van Neerven, R.J.; van Katwijk, M.; Bos, J.D.; Kapsenberg, M.L. Serum-IgE facilitated allergen presentation in atopic disease. J. Immunol. 1993, 150, 3643-3650.
36. Gioia, C.; Horejsh, D.; Agrati, C.; Martini, F.; Capobianchi, M.R.; Ippolito, G.; Poccia, F. T-Cell response profiling to biological threat agents including the SARS coronavirus. Int. J. Immunopathol. Pharmacol. 2005, 18, 525-530.
37. Matalon, R.; Surendran, S.; McDonald, J.D.; Okorodudu, A.O.; Tyring, S.K.; Michals-Matalon, K.; Harris, P. Abnormal expression of genes associated with development and inflammation in the heart of mouse maternal phenylketonuria offspring. Int. J. Immunopathol. Pharmacol. 2005, 18, 557-565.
38. Gasparetto, C.; Malinverno, A.; Culacciati, D.; Gritti, D.; Prosperini, P.G.; Specchia, G.; Ricevuti, G. Antioxidant vitamins reduce oxidative stress and ventricular remodelling in patients with acute myocardial infarction Int. J. Immunopathol. Pharmacol. 2005, 18, 487-496.
39. Banfield, C.C.; Callard, R.E.; Harper, J.I. The role of cutaneous dendritic cells in the immunopathogenesis of atopic dermatitis. Br. J. Dermatol. 2001, 144, 940-946.
40. Di Lorenzo, G.; De Placido, S. Hormone refractory prostate cancer (HRPC): present and future approaches of therapy. Int. J. Immunopathol. Pharmacol. 2006, 19, 11-34.
41. Pastore, L.; Fiore, J.R.; Tateo, M.; De Benedittis, M.; Petruzzi, M.; Casalino, C.; Genchi, C.; Lo Muzio, L.; Angarano, G.; Serpico, R. Detection of hepatitis C virus-RNA in saliva from chronically HCV-infected patients. Int. J. Immunopathol. Pharmacol. 2006, 19, 217-224.
42. Montalto, M.; Santoro, L.; Vastola, M.; Curigliano, V.; Ricci, R.; Vecchio, F.M.; Manna, R.; Gasbarrini, G. Normalisation of high CA 19-9 values in autoimmune hepatitis after steroidal treatment. Int. J. Immunopathol. Pharmacol. 2005, 18, 603-608.
43. Ohki, O.; Yokozeki, H.; Katayama, I.; Umeda, T.; Azuma, M.; Okumura, K.; Nishioka, K. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis. Br. J. Dermatol. 1997, 136, 838-845.
44. Riccioni, G.; Di Pietro, V.; Staniscia, T.; De Feudis, L.; Traisci, G.; Capani, F.; Ferrara, G.; Di Ilio, E.; Di Tano, G.; D'Orazio, N. Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index Int. J. Immunopathol. Pharmacol. 2005, 18, 575-586.
45. Artese, L.; Ucchino, S.; Piattelli, A.; Piccirilli, M.; Perrotti, V.; Mezzetti, A.; Cipollone, F. Factors associated with apoptosis in symptomatic and asymptomatic carotid atherosclerotic plaques. Int. J. Immunopathol. Pharmacol. 2005, 18, 645-654.
46. Cipollone, F.; Chiarelli, F.; Iezzi, A.; Fazia, M.L.; Cuccurullo, C.; Pini, B., De cesare, D.; Torello, M.; Tumini, S.; Cuccurullo, F.; Mezzetti, A. Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. Int. J. Immunopathol. Pharmacol. 2005, 18, 625-636.
47. Leggio, L.; Addolorato, G.; Abenavoli, L.; Gasbarrini, G. Wilson's disease: clinical, genetic and pharmacological findings. Int. J. Immunopathol. Pharmacol. 2005, 18, 7-14.
48. Bellinghausen, I.; Klostermann, B.; Knop, J.; Saloga, J. Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J. Allergy Clin. Immunol. 2003, 111 (4), 862-868.
49. Verhagen, J.; Akdis, M.; Traidl-Hoffmann, C.; et al. Absence of T-regulatory cell expression and function in atopic dermatitis. J. Allergy Clin. Immunol. 2006, 117, 176-183.
50. Cassano, N.; Puglisi Guerra, A.; Malara, C.; Loconsole, F.; Galluccio, A.; Pezza, M.; Vena, G.A. Re-induction as a possible alternative modality of dose escalation of infliximab: a prospective evaluation in a small series of psoriatic patients. Int. J. Immunopathol. Pharmacol. 2007, 20, 647-650.
51. Serpico, R.; Pannone, G.; Santoro, A; Mezza, E.; Piccolo, S.; Esposito, V.; Busciolano, M.; Ciavarella, D.; Lo Muzio, L.; Bufo, P. Report of a case of discoid lupus erythematosus localised to the oral cavity: immunofluorescence findings. Int. J. Immunopathol Pharmacol. 2007, 20, 651-653.